Top Stories
The alliance pairs enzymatic peptide engineering with physics-based AI modeling.
Cloud breach exposed proprietary information as the drugmaker launches an investigation.
The multi-year study will test whether OhmX can give labs a clearer view of structural variants in AML and MDS without having to piece together results from multiple tests.
The company's plan to bring provider-led GLP-1 prescribing and digital chronic care together is the first commercial offering to emerge from its partnership with Beluga Health.
The funding comes less than a year after the startup raised nearly $300 million in a series B round that valued Function at $2.5 billion.
Conference News
Following the introduction of Invenia™ ABUS Prime at the Society of Breast Imaging Annual Symposium, the installation at BeSound in Los Angeles marks one of the first in the U.S., expanding access to ...
Company will present two scientific posters examining the operational and readiness applications of its tAN® platform, marking a key step in Spark's expansion into the military-ready and first respond...
Second Quarter Revenue Growth of 52% to $132 MillionRaises 2026 Revenue Guidance to $490 Million to $500 Million and Raises 2026 AEBITDA Guidance to $66 Million to $78 MillionBRISBANE, Calif.--(BUSINE...
Second quarter 2026 revenue growth of 44% driven by strong performance in Oncology and ScreeningRaises 2026 revenue guidance to $1.34 to $1.36 billion, representing growth of 36% to 38%PALO ALTO, Cali...
Delivered Q2 2026 revenue of $103.5 millionQ2 2026 total test reports for our core revenue drivers (DecisionDx®-Melanoma, TissueCypher®) increased 32% over Q2 2025Raising full-year 2026 revenue guidan...
